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Abstract. The observations that live Mycobacterium leprae after entry into cultured
peritoneal macrophages from mice, reduced the EA rosetting macrophages, have been
exploited to determine the minimum inhibitory concentration of diamino diphenyl sulphone
and rifampicin. Diamino diphenyl sulphone showed a minimum inhibitory concentration of 
0·028 µg/ml and rifampicin 0·11 µg/ml when given externally. However, there was accumu-
lation of diamino diphenyl sulphone inside the macrophages. At an external concentration of 
0·028 µg/ml the concentration inside the macrophage was 0·5 µg/ml. The minimum inhibitory 
concentration for diamino diphenyl sulphone in this assay system is higher by several folds and 
that for rifampicin is slightly lower, than what is reported earlier with mice foot pad 
experiments. The minimum inhibitory concentration reported in this assay system is quite 
close to what is observed for in vitro inhibition of Mycobacterium lufu with both the drugs. 
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Introduction 
 
Among the drugs that are in clinical use against leprosy the diamino diphenyl sulphone 
(DDS) and rifampicin are most widely used, either individually or as components of 
recently introduced multidrug therapy (WHO, 1982). 
Due to nonavailability of an in vitro drug assay using Mycobacterium leprae, the 
minimum inhibitory concentration (MIC) has been reported using experimentally 
infected mice. The MIC for DDS has been determined as 0·003 µg/ml (Peters et al., 
1975) and for rifampicin as 0·3 µg/ml (Holmes and Hilson, 1972) based on the serum 
level. While this is an interesting and useful piece of information, less confidence is 
placed on these values in determining the dose of the drug given to the patients. The 
conventionally administered dose of 100 mg/day and 600 mg at a time, for DDS and 
rifampicin respectively, according to Allard (1980), provides a peak serum level of 500 and 
30 times the MIC. This is given perhaps, with the idea of avoiding development of drug 
resistant M. leprae in the patients. Thus the heavy dose of drug has no relationship to 
the MIC as determined in mice. It is thus useful to have a much more direct in vitro 
method of determining susceptibility of M. leprae to these drugs and the MIC. 
 
Abbreviations used: DDS, Diamino diphenyl sulphone; MIC, minimum inhibitory concentration; SRBC,  
sheep red blood cells. 
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It has been demonstrated that the presence of live M. leprae inside the macrophages 
from human or mice, reduced the level of Fc receptor expressing cells. This was not 
obtained with killed M. leprae (Birdi et al., 1983; Birdi and Antia, 1984; Mankar et al., 
1984). The basic conclusion derived from this study was that live M. leprae but not 
inactive M. leprae were able to alter the surface structure of macrophages. This surface 
structure alteration resulted in the reduction of Fc receptor expressing macrophages 
only in the presence of live M. leprae. Thus if drugs are active on M. leprae, then in the 
presence of the drug and M. leprae, Fc receptor expressing macrophages will not be 
reduced and the level will be as good as the control (Birdi and Antia, 1984; Mankar et 
al., 1984). 
In this report we present data indicating the MIC of DDS and rifampicin that would 
inactivate M. leprae, such an inactivation being determined using the above in vitro test 
system. 
 
 
Materials and methods  
DDS uptake by macrophages 
 
Macrophages from the peritoneal cavity of Swiss white mice were obtained and 
cultured in Leighton tubes as described previously (Mankar et al., 1984). Seventy two 
hours after distribution of macrophages, the drug DDS was added to the medium. After 
3 days of exposure to the drug, the cells were harvested by scraping them with a rubber 
policeman. They were washed 3 times with saline (0·85 %) to remove extracellular DDS. 
After suspending the macrophages in 1 ml saline, the cell count was taken in a 
haemocytometer. The macrophages were then lysed by subjecting them to 8 cycles of 
freeze-thawing. Distilled ethyl acetate (AR grade) was added to extract DDS from the 
macrophages. The extraction was done thrice by adding 2 ml ethyl acetate each time. To 
keep the pH basic, 0·5 ml of 10 Ν NaOH was added during the first extraction. The 
mixture was vortexed each time to facilitate the extraction of DDS from the lysate to 
the ethyl acetate layer (Allard and Gammon, 1969; Ozawa et al., 1971; Peters et al., 
1981). 
After separation of the solvent and aqueous phase in 20 min, the ethyl acetate phase 
was transferred to another tube with a pasteur pippette. To the ethyl acetate phase 
0·5 gm of NaCl (AR grade) was added to remove water molecules carried during the 
extraction. The ethyl acetate phase was then allowed to separate from the NaCl which 
sedimented at the bottom. The ethyl acetate phase was removed and checked for 
fluorescence on a spectrofluorimeter (SFM23-Kontron). This assay method provided a 
sensitivity upto 2 ng/ml for DDS at wavelength settings of 285 nm for excitation and 
350 nm for emission. A culture of macrophage, which had not been exposed to the drug 
otherwise treated exactly the same as the experimental served as control. 
DDS (in ng)/106 macrophages is equal to a fluorescence level of 1 × 106 experimental
macrophages, from which the fluorescence level of 1 × 106 control macrophages was 
subtracted. The quantitation was done using a standard curve (experimentally 
determined) of fluorescence units against increasing concentrations of DDS added to
macrophage cultures. 
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Volume measurement 
 
The macrophages exposed to DDS as described earlier were suspended in osmolar
saline and a drop was placed on a wax coated slide. The macrophages which had settled 
appeared rounded and uniformly circular under microscopic observation. The 
diameter of macrophages was measured using previously calibrated ocular micrometer. 
One hundred macrophages were scanned and the diameter was measured, to determine 
the average diameter. The volume of a macrophage was calculated using the formula, 
V = 4/3 πr3 where r is radius, which was determined as 10 µm (table 1). Thus 
V = 4/3 × 3·17 × (10 × 10-4)· This worked out to be 4·2 × 10-9 cc for a single 
macrophage. 
 
Determination of minimum inhibitory dose of DDS for M· leprae 
The determination of minimum external dose necessary to inhibit the M. leprae inside 
the macrophage was done by the EA rosetting technique· Mouse peritoneal macro-
phage cultures were set and 72 h later the drug sulphone (Burroughs Welcome India) 
was added in known concentrations· After exposure of the culture to the drug for 72 h, 
they were washed to remove the external DDS and were infected with M. leprae 
(armadillo derived)· The extracellular drug was removed so as to avoid killing of 
M. leprae outside the cells· After the removal of extracellular DDS, there was very little 
diffusion of (5 % of internal level) cellular DDS to outside during the 72 h of incubation. 
M. leprae were phagocytosed by macrophages and were allowed to interact with the 
drug inside macrophages for 72 h (5 × 106 M. leprae/tube was the dose)· On the day of 
termination all the cultures were washed to remove the excess bacilli and subjected to 
EA rosetting with antibody coated sheep red blood cells (SRBC) (Mankar et al., 1984)· 
M. leprae was prepared from infected armadilllo tissue adopting the procedure of 
Ambrose et al. (1978)· In all our experiments there was very little or no phagocytosis of 
SRBC by the macrophages. 
 
Results 
 
The radius of cultured macrophages was found to be 10 μm as an average value 
determined from several experiments using different concentrations of DDS and 100 
cells in each experiment (table 1). This radius was used to calculate the volume of the 
macrophages and the volume was determined to be 4·2 × 10-9 cc for a single 
macrophage· The macrophages mostly retained a uniform circular shape· To avoid 
experimental variation several experiments were done as stated above and the average 
value has been used. 
The percentage of macrophages expressing Fc receptors was reduced in the presence 
of dive M. leprae. In the presence of appropriate concentration of DDS in the 
incubation fluid, this Fc reduction was counteracted (table 2)·At DDS concentrations of 
14·2ng/ml and 21·4ng/ml, the level of Fc receptor expressing macrophages in the 
presence of live M. leprae was 24 ± 6 and 46 ± 7 % as compared to the control values of 
49 ± 14 and 70 ± 1 % respectively· However concentrations of DDS at 28·5 ng/ml and 
above completely reversed the lowered level of Fc receptor containing macrophages 
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Table 1. Average radius of macrophage in culture while exposed to varying concentrations 
of DDS. 
 
Total no. of cells counted was 100 in each of the experiment and two experiments were 
conducted at each concentration of DDS. 
 
Table 2. Percentage of macrophage exhibiting EA rosetting in the presence of M, leprae and 
various concentrations of DDS. 
*The value for each concentration of DDS is the mean of 4 experiments. Ρ value is for data 
calculated for each concentration of the drug separately. 
Α-B, Ρ < 0·05; A-C, Ρ < 0·05; Α-D, Ρ < 0·05 upto 15ng;A-E, Ρ > 0·05; B-D, Ρ > 0·05 upto 
15 ng. Significance calculated by Student's t distribution test. 
† A different sample of amboceptor (antibody) for SRBC was used in this set of experiment and so 
the values are lower for this concentration. 
 
 
caused by live M. leprae. This indicated the drug, induced inactivation of M. leprae at 
this concentration· The cultures using heat killed M. leprae showed the same rosetting 
ability as the control where no live M. leprae was added, the results being similar to 
those cultures treated with live M, leprae and concentration of DDS at 28·5 ng/ml or 
higher· The drug by itself, in the absence of M. leprae lowered the Fc receptor 
containing macrophages· This was noteworthy, but as we were looking for a reversal of 
the lowered Fc receptor level to higher level in the presence of the drug and M. leprae the 
effect of drug by itself is of little significance in this connection. 
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Table 3 presents data that were calculated to determine the DDS concentration of 
macrophages (µg/ml of the cells) using various concentrations of the drug in the 
culture· It is clearly seen that the concentration of the drug inside the macrophages 
increases with increasing concentration of the drug that was provided outside the cells. 
From table 2 it is clear that at 28·5 ng/ml (external concentration) DDS inactivates 
M. leprae, so as to block its effect on the membrane of the macrophages and thereby 
prevent the reduction of Fc receptor bearing macrophages· At this concentration of 
28·5 ng/ml, the level of DDS inside the macrophages is 0·50 µg/ml, the range varying 
from 0·3 µg–0·6 µg/ml. 
Data presented in table 4 show that a minimum concentration of 114 ng/ml of 
rifampicin (Sigma, USA) is needed to inactivate the M. leprae inside the macrophages· 
This was shown by the restoration of the normal level of Fc receptor macrophages when 
this concentration of the drug was used in the presence of live M. leprae. 
 
 
Table 3. Level of DDS inside macrophages (as µg/ml) on exposure to various amounts of the drug.
* Value determined as mean ± S.D. from 4 experiments at each concentration of DDS. The volume of 
macrophage used for calculation was 4·2 × 10-3 cc/106 macrophage. 
 
 
Table 4. Percentage of macrophages exhibiting EA rosetting in the presence of M. leprae and at various 
concentration of rifampicin. 
* 3 experiments were carried out for each concentration and the mean ± S.D. is presented. 5 × 106/Leighton 
tube of M. leprae was used. 
Significance of difference (Student's t distribution test). Ρ value is for data under each concentration of 
rifampicin used. 
Α-B, Ρ < 0·05; A-C, Ρ < 0·05; Α-D, Ρ < 0·05 upto 50ng only; A-E, P > 0·05; B-D, Ρ > 0·05 upto 50 ng 
only.
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Discussion 
 
The MIC for DDS using the Fc receptor assay system appears to be 28 ng/ml of the 
medium. Satish and Nath (1981) and Nath et al. (1982) in their experiments had shown 
that at 10 ng/ml level of DDS, [3H]-thymidine incorporation by M. leprae could be 
considerably reduced and even 3 ng/ml was also shown to be active to some extent· This 
was explained as being in agreement with the MIC for DDS reported from mice 
experiments· However the basic fact that the drug accumulated inside the macrophages 
was not taken into consideration, which is an important feature in any assay using host 
cells·At an outside concentration of 10 ng/ml the expected concentration inside the 
macrophages is 0·30-0·38 µg/ml as seen in our experiments. 
When the concentration of DDS in the culture was varied from 10-500 ng there was 
an increasing level of DDS inside the macrophages, although a linear relationship was 
seen only in the lower concentration range of 10–100 ng levels (table 3)· This lower 
range is quite satisfactory for our experimental purpose; since at these levels DDS is 
active. 
Seydel and Wempe (1982) had shown that M. lufu which appears as the best model 
organism to study the action of DDS, the inactivation and growth inhibition occurred 
at an MIC of 0·03-0·05 µg/ml and this is quite close to the external DDS concentration 
observed in our assay system (0·028 µg/ml). 
DDS has the ability to bind to proteins and some of the internal DDS could be 
protein bound· Since we extract DDS with ethyl acetate it is possible that the protein-
bound fraction is also included in the estimation and therefore the active free DDS 
concentration inside M. leprae may be even lower. 
In mice foot pad experiments the MIC determined on the basis of the serum level of 
DDS can give only part of the information, since the bacteria that are to be killed are in 
the foot pad and therefore the accumulated level of DDS in the local tissue is the most 
relevant parameter· The accumulated level will depend on storage and degradation of 
the drug in the tissues· It has been reported that the tissue level is likely to be 2-fold that 
of the serum level. Gordon et al. (1974) have reported that the serum level of DDS, when 
mice were given 0·002% DDS in the diet, was 180 ng/ml and in the tissue it was 1·6 
times higher. Shepard (1967) calculated an MIC of 0·01-0·03 μg/ml and Ozawa et al. 
(1971) reported it to be 2·5-10 ng/ml· Allard et al. (1971) concluded that the MIC of 
DDS to M. leprae is less than 10 ng/ml, based on the serum level· Holmes and Hilson 
(1972) have shown that the serum value at 0·0001 % of DDS in diet was between 
0·01- 0·03 µg/ml. This is similar to the value recorded by us. The often quoted report of 
Peters et al. (1975) indicating an MIC value of 0·003 μg/ml in rats and by Levy and 
Peters (1976) in mice, is in close agreement with the value obtained in the present study. 
The level of an MIC of 28 ng/ml needed in our test system may probably be due to 
the fact that our experiments are limited to only 72 h exposure of the bacteria to the 
drug compared to the exposure of M. leprae in mouse foot pad for several weeks to the 
lowest reported level of 6 ng/ml (or perhaps higher) of the drug in the tissue before any 
viability is checked· Seydel and Wempe (1982) using the cell free enzyme system showed 
that the concentration required to lower the folate synthesizing enzyme activity from 
M. lufu by 50 % with DDS was 0·084 µg/ml (0·42 μΜ). They also pointed out that the 
DDS concentration needed for in vitro inactivation of the enzyme is definitely much 
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higher than 0·003 µg/ml reported as the MIC· Thus it is quite probable that the 
accumulated tissue level of DDS acts on M. leprae in mice foot pad experiments. 
In patients receiving 100 mg/day, DDS reached peak serum levels of 2·5-6 µg/ml 
(Modderman et al., 1983)· Thus the serum level is at least 5-12 times more than the MIC 
determined by the present method. So it can be argued that a level even lower than 
100 mg/day should be quite sufficient as a therapeutic dose· It could also be mentioned 
that sulpha drugs are always given at a dose level capable of completely inactivating the 
folate synthesizing enzyme. 
In comparison to DDS, rifampicin directly blocks the multiplication of bacteria and 
it is bactericidal· The MIC determined in the mice was 0·3 µg/ml (Holmes and Hilson, 
1972). In our system we needed a minimum external dose of 0·114 µg/ml 
(80 ng/Leighton tube) to inactivate M. leprae inside the macrophages. 
It has not been possible to estimate the concentration of rifampicin inside the
macrophages when a concentration of 0·114 µg/ml (80 ng/Leighton tube) is given· The 
sensitivity of the bioassay is only up to a level above 0·1 µg/ml. Thus the level of 
accumulation cannot be more than 0·1 µg/ml and this needs further investigation· It is 
possible that there is accumulation of rifampicin inside the macrophages and the actual 
concentration of the drug to which M. leprae inside the cells is exposed could be higher 
than the external concentration· Using M. lufu as test organism, the MIC of rifampicin 
is reported to be 0·25 µg/ml by Seydel et al. (1982). 
The potentiality of determining the MIC of a drug using the Fc receptor assay, can 
also help us to determine the synergistic effect of one drug in the presence of another. 
Such studies have been completed using this assay system with two drugs DDS and 
Brodimoprim (Seydel et al., 1983; Jagannathan and Mahadevan, 1985). 
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